A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland - Wikidata - awgldk - TriplyDB

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

http://www.wikidata.org/entity/Q28365264

about

A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women.Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications Genetic variation: effect on prostate cancer.Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes Hormones and prostate cancer: current perspectives and future directions.Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.Pharmacogenetics of human androgens and prostate cancer--an update.Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer.Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.5α-Reductase Isozymes in the Prostate Genomic biomarkers, androgen pathway and prostate cancer.No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.Association between hormonal genetic polymorphisms and early-onset prostate cancer.Significant impact of 5alpha-reductase type 2 polymorphisms on sperm concentration and motility.5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.

P2860

Q24796415-9C92B04B-63D7-44B5-A39F-83CBF2982FDC Q33672581-F3E6A558-3CE4-414C-A7DB-49B4A19AE448 Q34663656-9B4B926A-6056-4648-8CFC-C9D6796FD1D1 Q34722941-352EF8D5-4647-4B26-BB1B-908AC5516B7E Q34732880-38DF1815-BB33-401F-BF76-489751961D5B Q35540054-4A320D21-E12F-4037-A2A8-73C8888A0DDC Q35753329-4F88D9D4-69CE-4D4B-932B-F2EB0F5F65C8 Q36395111-D523D70C-E321-4D22-A8BA-ECEEDB665D4E Q36430744-B8F38880-937B-4668-925A-849676769877 Q36661343-2DD4AC35-CE9D-4F1C-A685-F04410ABF14E Q36845131-28D07071-B499-489C-9C2D-B1B0DAF94C4C Q37294754-ED23FA3F-C323-4804-9600-A2F0A331BB79 Q37633264-E77EFD96-6726-45AA-A2CB-C4C1EF7A2E2E Q43595675-E6DEC0A5-A40B-431E-9395-488B8542DE9A Q44059679-E3F74101-87DB-4994-9B93-982923CFC030 Q44124773-753B265B-E678-4EAC-90D3-34036EB9D900 Q45265466-DEAC8D2B-7173-488C-9288-171CA5551C53 Q46951247-B26BEA7C-BB2B-4E3E-B1CC-0D7462787D7C Q54569428-999E72EF-8DE5-40B3-8822-2A5C956222B0

P2860

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

http://www.wikidata.org/entity/Q28365264

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

A missense substitution A49T i ...... ith prostate cancer in Finland

@ast

A missense substitution A49T i ...... ith prostate cancer in Finland

@en

A missense substitution A49T i ...... ith prostate cancer in Finland

@nl

type

label

A missense substitution A49T i ...... ith prostate cancer in Finland

@ast

A missense substitution A49T i ...... ith prostate cancer in Finland

@en

A missense substitution A49T i ...... ith prostate cancer in Finland

@nl

prefLabel

A missense substitution A49T i ...... ith prostate cancer in Finland

@ast

A missense substitution A49T i ...... ith prostate cancer in Finland

@en

A missense substitution A49T i ...... ith prostate cancer in Finland

@nl

P1433

Q28365264-254099D6-7225-49B2-B29E-92CAFF425EA6

P1476

Q28365264-7D789187-4C7A-4A35-BD11-588A6C7FB98D

P2093

Q28365264-09902B82-739B-40D3-8CA7-675FDDE22531

Q28365264-5CF62811-27D9-4317-95ED-ED1D540FE98F

Q28365264-8E3ABB6C-3F54-4D97-AE13-D50184990790

Q28365264-95987941-3368-4785-86E1-EC0356070EFB

Q28365264-9933C6C3-1E2D-4D74-B87F-3C2A7089EE4B

Q28365264-C21DC260-FB75-4FA0-AE08-D88BDA4B128B

Q28365264-FAEB7AE6-32A7-4091-A5B7-585E60EA4D36

P2860

Q28365264-03C4AED4-79AB-4294-B11B-86F1AC40C921

Q28365264-14C6372A-0D97-484E-95CE-FC84F0C4F467

Q28365264-24D4FFF4-0A61-41D9-9ED1-5202F4DA91BC

Q28365264-3A620FBF-AC6B-42E2-9165-4183BAE8EA2F

Q28365264-4F3D8BEC-9EA5-4C14-9DB4-E5111B85B057

Q28365264-5D0A51B4-3E74-440D-89CB-15904282A308

Q28365264-620EB2C8-462C-4AFA-9A0B-2F46A6DB3A63

Q28365264-720F0F9D-33CA-4A65-9D44-3F5A5198D8D5

Q28365264-996525D1-9271-4A9F-BF1C-69CDA6D686F6

Q28365264-9B158E6B-2D9F-49CC-A156-A74EE46738A0

P2888

Q28365264-408F7101-B499-4366-B34E-A0040804A914

P304

Q28365264-920F69E5-BA75-452D-85EB-9C2F777195DE

P31

Q28365264-15D9733C-259D-4C72-A1F9-2FF4253A8B78

P356

Q28365264-54AD9B50-598C-48CD-A0EA-06AB8514E2D9

P407

Q28365264-650FE76F-7435-4192-ABF2-8313C9E5D35A

P433

Q28365264-EC2A7DDA-0AFB-4429-8350-76B0D00220E5

P478

Q28365264-FE114CC6-ABBA-4720-9D7D-B04E8AE6B523

P50

Q28365264-F4A9144D-E775-4722-884E-A849F8EECD00

P577

Q28365264-88486253-2753-418F-A3C4-0C68B635243C

P5875

Q28365264-8E6D4BDD-863E-4087-9C16-8D6F5EC9E727

P6179

Q28365264-3F9D1801-DAE8-4FE1-A418-AF408A428C24

P698

Q28365264-7607F2DA-A299-476F-80F3-8FBA3CF09502

P921

Q28365264-2A89F065-0FD9-4953-97DC-A4BD66B4F8C6

P932

Q28365264-39450833-410A-4F86-B601-38ED63A843E5

P356

P1433

British Journal of Cancer

P1476

A missense substitution A49T i ...... ith prostate cancer in Finland

@en

P2093

J Schleutker

http://www.w3.org/2001/XMLSchema#string

K Syrjäkoski

http://www.w3.org/2001/XMLSchema#string

M Matikainen

http://www.w3.org/2001/XMLSchema#string

N Mononen

http://www.w3.org/2001/XMLSchema#string

P A Koivisto

http://www.w3.org/2001/XMLSchema#string

T Ikonen

http://www.w3.org/2001/XMLSchema#string

T L Tammela

http://www.w3.org/2001/XMLSchema#string

P2860

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families

A genomic scan of families with prostate cancer identifies multiple regions of interest.

Evidence for a prostate cancer-susceptibility locus on chromosome 20.

A genome screen of multiplex sibships with prostate cancer.

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

The endocrinology and developmental biology of the prostate.

P2888

P304

1344-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1789

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

P577

2001-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11981918

http://www.w3.org/2001/XMLSchema#string

P6179

1002635718

http://www.w3.org/2001/XMLSchema#string

P698

11355945

http://www.w3.org/2001/XMLSchema#string

P921

P932

2363646

http://www.w3.org/2001/XMLSchema#string